Research Article
Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis
Table 2
Data of study subjects.
| Patients () | 43 | Female/male () | 25/18 | Age at diagnosis (years) | 33.26 ± 9.88 | Disease duration (years) | 2.22 ± 3.35 | EDSS acute | 2.72 ± 0.95 | EDSS remission | 1.93 ± 0.96 | EDSS final | 2.66 ± 1.90 | ARR (total) | 0.43 ± 0.56 | Follow-up duration (years) | 5.31 ± 1.58 | IgG index | 1.02 ± 0.62 | T2 lesions (baseline) | 10.51 ± 5.52 | T1 Gd+ lesions (baseline) | 2.16 ± 2.12 | CSF cell number (per L) | 9.72 ± 8.29 |
|
|
Data are presented as mean ± SD; T1 Gd+: gadolinium enhancing lesions.
|